Q2 2026 Holdings
Filed 2026-08-13 | 119 holdings | $4.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Scholar Rock Holding Corp(SRRK) | COM | 80706P103 | $526.6M | 9,575,013 | 10.7% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $336.7M | 2,935,830 | 6.8% |
| Erasca Inc(ERAS) | COM | 29479A108 | $208.8M | 11,397,781 | 4.2% |
| Veradermics Inc(MANE) | COMMON STOCK | 922967104 | $203.5M | 1,655,374 | 4.1% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $193.2M | 6,179,364 | 3.9% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $168.6M | 900,000 | 3.4% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $166.4M | 5,602,970 | 3.4% |
| Arrowhead Pharmaceuticals Inc(ARWR) | COM | 04280A100 | $139.8M | 1,715,476 | 2.8% |
| BeOne Medicines AG(ONC) | SPONSORED ADS | 07725L102 | $132.5M | 465,000 | 2.7% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $129.4M | 3,184,629 | 2.6% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $126.2M | 1,136,275 | 2.6% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $106.3M | 44,303,518 | 2.2% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $90.1M | 1,774,411 | 1.8% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $86.0M | 968,598 | 1.7% |
| Parabilis Medicines Inc(PBLS) | COM | 698955101 | $81.9M | 2,992,259 | 1.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $79.6M | 1,318,564 | 1.6% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $76.8M | 7,690,405 | 1.6% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $76.8M | 576,000 | 1.6% |
| Hemab Therapeutics Holdings Inc(COAG) | COM SHS | 423494103 | $76.6M | 2,086,834 | 1.6% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $74.6M | 2,420,430 | 1.5% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $72.0M | 1,859,279 | 1.5% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $68.3M | 3,650,000 | 1.4% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $67.1M | 9,846,579 | 1.4% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $66.8M | 1,419,493 | 1.4% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $65.3M | 1,995,347 | 1.3% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $65.0M | 888,401 | 1.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $64.7M | 758,952 | 1.3% |
| Septerna Inc(SEPN) | COM | 81734D104 | $63.6M | 1,900,000 | 1.3% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $60.8M | 4,856,949 | 1.2% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $53.2M | 1,420,788 | 1.1% |
| Kailera Therapeutics Inc(KLRA) | COMMON STOCK | 482931102 | $48.8M | 2,214,286 | 1.0% |
| Dyne Therapeutics, Inc(DYN) | COM | 26818M108 | $47.3M | 2,129,125 | 1.0% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $46.9M | 872,967 | 0.9% |
| Taboola.com Ltd(TBLA) | ORD SHS | M8744T106 | $42.1M | 8,423,410 | 0.9% |
| Palvella Therapeutics Inc(PVLA) | COM | 697947109 | $39.3M | 257,485 | 0.8% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $36.4M | 3,311,438 | 0.7% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $35.9M | 1,396,513 | 0.7% |
| Remitly Global Inc(RELY) | COM | 75960P104 | $34.6M | 1,543,271 | 0.7% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $34.5M | 1,893,410 | 0.7% |
| Capital One Finl Corp(COF) | COM | 14040H105 | $34.4M | 171,615 | 0.7% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $33.3M | 1,786,867 | 0.7% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $32.5M | 2,998,192 | 0.7% |
| Alphabet Inc(GOOGL) | CAP STK CL A | 02079K305 | $32.2M | 90,000 | 0.7% |
| Dbv Technologies SA(DBVT) | SPONSORED ADS | 23306J309 | $30.5M | 1,857,362 | 0.6% |
| Absci Corp(ABSI) | COM | 00091E109 | $28.7M | 2,474,764 | 0.6% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $26.9M | 610,515 | 0.5% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $26.7M | 641,469 | 0.5% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $26.6M | 1,480,586 | 0.5% |
| Annexon Inc(ANNX) | COM | 03589W102 | $25.5M | 4,458,646 | 0.5% |
| Monopar Therapeutics Inc(MNPR) | COM NEW | 61023L207 | $25.0M | 270,118 | 0.5% |